Katja Harbst

6PUBLICATIONS
57CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisCancer geneticsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 19, 2026
SWE-NEO: Swedish NEO-adjuvant trial comparing anti-PD-1 monotherapy to combined anti-CTLA-4/anti-PD-1 blockade in resectable stage III melanoma: study protocol for a phase III open-label multi-centre trial.

Hildur Helgadottir, Ana Carneiro, Francesca Portelli

|Dec 03, 2025
Pericytes orchestrate a tumor-restraining microenvironment in glioblastoma.

Sebastian Braun, Paulina Bolivar, Clara Oudenaarden

|Apr 09, 2024
Molecular patterns of resistance to immune checkpoint blockade in melanoma.

Martin Lauss, Bengt Phung, Troels Holz Borch

|Feb 03, 2024
BioMEL: a translational research biobank of melanocytic lesions and melanoma.

Teo Helkkula, Gustav Christensen, Christian Ingvar

|Sep 04, 2020
Pervasive chromosomal instability and karyotype order in tumour evolution.

Thomas B K Watkins, Emilia L Lim, Marina Petkovic

|Apr 03, 2020
Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma.

Martin Lauss, Marco Donia, Katja Harbst

Pageof 1

Frequent Collaborators

2 joint publications

Göran Jönsson

2 joint publications

Kristian Pietras

2 joint publications

Kari Nielsen

1 joint publications

Roger Olofsson Bagge